1011 related articles for article (PubMed ID: 29070502)
1. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension.
Weatherald J; Boucly A; Launay D; Cottin V; Prévot G; Bourlier D; Dauphin C; Chaouat A; Savale L; Jaïs X; Jevnikar M; Traclet J; De Groote P; Simonneau G; Hachulla E; Mouthon L; Montani D; Humbert M; Sitbon O
Eur Respir J; 2018 Oct; 52(4):. PubMed ID: 30209196
[TBL] [Abstract][Full Text] [Related]
3. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
[TBL] [Abstract][Full Text] [Related]
4. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry).
Barst RJ; Ivy DD; Foreman AJ; McGoon MD; Rosenzweig EB
Am J Cardiol; 2014 Jan; 113(1):147-55. PubMed ID: 24176071
[TBL] [Abstract][Full Text] [Related]
5. Right Heart Score for Predicting Outcome in Idiopathic, Familial, or Drug- and Toxin-Associated Pulmonary Arterial Hypertension.
Haddad F; Spruijt OA; Denault AY; Mercier O; Brunner N; Furman D; Fadel E; Bogaard HJ; Schnittger I; Vrtovec B; Wu JC; de Jesus Perez V; Vonk-Noordegraaf A; Zamanian RT
JACC Cardiovasc Imaging; 2015 Jun; 8(6):627-38. PubMed ID: 25981508
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension.
Boucly A; Weatherald J; Savale L; Jaïs X; Cottin V; Prevot G; Picard F; de Groote P; Jevnikar M; Bergot E; Chaouat A; Chabanne C; Bourdin A; Parent F; Montani D; Simonneau G; Humbert M; Sitbon O
Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775050
[TBL] [Abstract][Full Text] [Related]
7. Fluid challenge predicts clinical worsening in pulmonary arterial hypertension.
D'Alto M; Motoji Y; Romeo E; Argiento P; Di Marco GM; Mattera Iacono A; D'Andrea A; Rea G; Golino P; Naeije R
Int J Cardiol; 2018 Jun; 261():167-171. PubMed ID: 29559180
[TBL] [Abstract][Full Text] [Related]
8. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
9. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
10. Pressure-Flow During Exercise Catheterization Predicts Survival in Pulmonary Hypertension.
Hasler ED; Müller-Mottet S; Furian M; Saxer S; Huber LC; Maggiorini M; Speich R; Bloch KE; Ulrich S
Chest; 2016 Jul; 150(1):57-67. PubMed ID: 26892603
[TBL] [Abstract][Full Text] [Related]
11. The Value of Hemodynamic Measurements or Cardiac MRI in the Follow-up of Patients With Idiopathic Pulmonary Arterial Hypertension.
van der Bruggen CE; Handoko ML; Bogaard HJ; Marcus JT; Oosterveer FPT; Meijboom LJ; Westerhof BE; Vonk Noordegraaf A; de Man FS
Chest; 2021 Apr; 159(4):1575-1585. PubMed ID: 33197401
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of Hemodynamics With Right Heart Catheterization in Children With Pulmonary Arterial Hypertension.
Grynblat J; Malekzadeh-Milani SG; Meot M; Perros F; Szezepanski I; Morisset S; Ovaert C; Bonnet C; Maragnes P; Ranchoup J; Humbert M; Montani ID; Levy M; Bonnet D
J Am Heart Assoc; 2023 Apr; 12(7):e029085. PubMed ID: 36974756
[TBL] [Abstract][Full Text] [Related]
13. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
[TBL] [Abstract][Full Text] [Related]
14. [Hemodynamic Predictors of Clinical Deterioration in Patients With Pulmonary Arterial Hypertension Associated With Systemic Scleroderma].
Nikolaeva EV; Kurmukov IA; Yudkina NN; Glukhova SI; Volkov AV
Kardiologiia; 2016 Oct; 56(10):46-54. PubMed ID: 28290895
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.
Ghio S; D'Alto M; Badagliacca R; Vitulo P; Argiento P; Mulè M; Tuzzolino F; Scelsi L; Romeo E; Raineri C; Martino L; Tamburino C; Poscia R; Vizza CD
Int J Cardiol; 2017 Mar; 230():53-58. PubMed ID: 28038821
[TBL] [Abstract][Full Text] [Related]
16. Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.
Thenappan T; Glassner C; Gomberg-Maitland M
Chest; 2012 Mar; 141(3):642-650. PubMed ID: 21885728
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
[No Abstract] [Full Text] [Related]
18. Prognostic value of follow-up vasoreactivity test in pulmonary arterial hypertension.
Ishii S; Hatano M; Maki H; Minatsuki S; Saito A; Yagi H; Shimbo M; Soma K; Numata G; Fujiwara T; Takeda N; Komuro I
J Cardiol; 2023 Jul; 82(1):69-75. PubMed ID: 36682710
[TBL] [Abstract][Full Text] [Related]
19. The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension.
Nickel N; Golpon H; Greer M; Knudsen L; Olsson K; Westerkamp V; Welte T; Hoeper MM
Eur Respir J; 2012 Mar; 39(3):589-96. PubMed ID: 21885392
[TBL] [Abstract][Full Text] [Related]
20. Functional class improvement and 3-year survival outcomes in patients with pulmonary arterial hypertension in the REVEAL Registry.
Barst RJ; Chung L; Zamanian RT; Turner M; McGoon MD
Chest; 2013 Jul; 144(1):160-168. PubMed ID: 23429998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
